PL2185937T5 - Sposób wykrywania posocznicy u ludzi - Google Patents

Sposób wykrywania posocznicy u ludzi

Info

Publication number
PL2185937T5
PL2185937T5 PL08801791T PL08801791T PL2185937T5 PL 2185937 T5 PL2185937 T5 PL 2185937T5 PL 08801791 T PL08801791 T PL 08801791T PL 08801791 T PL08801791 T PL 08801791T PL 2185937 T5 PL2185937 T5 PL 2185937T5
Authority
PL
Poland
Prior art keywords
sepsis
humans
assaying
psp
serum
Prior art date
Application number
PL08801791T
Other languages
English (en)
Polish (pl)
Other versions
PL2185937T3 (pl
Inventor
Rolf Graf
Daniel Bimmler
Marius Keel
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40040164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2185937(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Zuerich filed Critical Univ Zuerich
Publication of PL2185937T3 publication Critical patent/PL2185937T3/pl
Publication of PL2185937T5 publication Critical patent/PL2185937T5/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/474Pancreatic thread protein; Reg protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
PL08801791T 2007-09-07 2008-09-02 Sposób wykrywania posocznicy u ludzi PL2185937T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07017539 2007-09-07
PCT/EP2008/007158 WO2009030456A1 (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans
EP08801791.8A EP2185937B2 (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans

Publications (2)

Publication Number Publication Date
PL2185937T3 PL2185937T3 (pl) 2012-02-29
PL2185937T5 true PL2185937T5 (pl) 2014-12-31

Family

ID=40040164

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08801791T PL2185937T5 (pl) 2007-09-07 2008-09-02 Sposób wykrywania posocznicy u ludzi

Country Status (13)

Country Link
US (2) US8435755B2 (OSRAM)
EP (1) EP2185937B2 (OSRAM)
JP (1) JP5048838B2 (OSRAM)
CN (1) CN101796418B (OSRAM)
AT (1) ATE514950T1 (OSRAM)
AU (1) AU2008295046B2 (OSRAM)
CA (1) CA2696319C (OSRAM)
DK (1) DK2185937T4 (OSRAM)
ES (1) ES2368877T5 (OSRAM)
NZ (1) NZ583474A (OSRAM)
PL (1) PL2185937T5 (OSRAM)
PT (1) PT2185937E (OSRAM)
WO (1) WO2009030456A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2577316T3 (en) 2010-05-31 2017-05-08 Univ Hospital Of Basel Procedure for testing for lower respiratory tract infections or inflammation
HUE050775T2 (hu) 2010-08-31 2021-01-28 Univ Otto Von Guericke Magdeburg Eljárás fertõzõ peritonitis diagnosztizálására, és súlyosságának és kimenetelének elõre történõ meghatározására emberben
US20130004968A1 (en) * 2010-09-22 2013-01-03 Robert Webber Sepsis blood biomarker system
WO2014009480A1 (en) 2012-07-12 2014-01-16 Universität Zürich Method for assaying sepsis and outcome in humans by detection of psp/reg
US20140120174A1 (en) * 2012-10-30 2014-05-01 Lascco, Sa Methods of prognosis and diagnosis of sepsis
US20150362509A1 (en) * 2013-01-28 2015-12-17 Vanderbilt University Method for Differentiating Sepsis and Systemic Inflammatory Response Syndrome (SIRS)
EP2813852A3 (en) 2013-06-11 2015-03-25 University Of Zurich Method for detecting the development of an infection in humans
CN106367488A (zh) * 2016-08-29 2017-02-01 北京泱深生物信息技术有限公司 Letmd1在脓毒症诊断中的应用
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
EP3971573A1 (en) 2017-09-13 2022-03-23 B.R.A.H.M.S GmbH Proadrenomedullin as a marker for abnormal platelet levels
EP3502706A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
CN108181472B (zh) * 2018-03-05 2020-07-21 吉林大学 昆虫细胞表达psp为校准品的检测psp试剂盒
EP3578989A1 (en) 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
FR3087338B1 (fr) * 2018-10-22 2020-10-09 Amadeite Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
WO2022096916A1 (en) * 2020-11-03 2022-05-12 Abionic Sa Method for assessing the severity of sars
JP2024542180A (ja) * 2021-11-25 2024-11-13 アビオニック・ソシエテ・アノニム 抗生物質投与の管理方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4837990A (en) * 1988-12-21 1990-07-10 General Hospital Corporation, The Method of detecting neurological disease or dysfunction
GB9613629D0 (en) * 1996-06-28 1996-08-28 Univ Leeds Reg gene expression in cancer tissue
ATE272214T1 (de) * 2001-12-04 2004-08-15 Brahms Ag Verfahren zur diagnose von sepsis unter bestimmung von s100b
DE50105971D1 (de) * 2001-12-04 2005-05-25 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
EP1318404B1 (de) * 2001-12-04 2004-07-28 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9
ATE282831T1 (de) * 2001-12-04 2004-12-15 Brahms Ag Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
JP2004194534A (ja) * 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
DE602004015064D1 (de) * 2003-01-06 2008-08-28 Wyeth Corp Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US20070224638A1 (en) * 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
DK2577316T3 (en) * 2010-05-31 2017-05-08 Univ Hospital Of Basel Procedure for testing for lower respiratory tract infections or inflammation

Also Published As

Publication number Publication date
CN101796418A (zh) 2010-08-04
EP2185937B1 (en) 2011-06-29
DK2185937T4 (da) 2014-10-20
EP2185937B2 (en) 2014-07-16
US9857381B2 (en) 2018-01-02
JP2010538282A (ja) 2010-12-09
PL2185937T3 (pl) 2012-02-29
CA2696319C (en) 2021-02-02
US20100222223A1 (en) 2010-09-02
ES2368877T3 (es) 2011-11-23
AU2008295046B2 (en) 2013-08-01
CA2696319A1 (en) 2009-03-12
US8435755B2 (en) 2013-05-07
AU2008295046A1 (en) 2009-03-12
NZ583474A (en) 2011-07-29
DK2185937T3 (da) 2011-09-12
ES2368877T5 (es) 2014-10-20
EP2185937A1 (en) 2010-05-19
WO2009030456A1 (en) 2009-03-12
ATE514950T1 (de) 2011-07-15
CN101796418B (zh) 2013-05-01
US20130203612A1 (en) 2013-08-08
JP5048838B2 (ja) 2012-10-17
PT2185937E (pt) 2011-09-06

Similar Documents

Publication Publication Date Title
PL2185937T5 (pl) Sposób wykrywania posocznicy u ludzi
NZ602056A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE504002T1 (de) Erkennung und vorhersage von frühgeburten
NZ630277A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012175741A3 (en) Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
MXPA05011826A (es) Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46.
MX2009000914A (es) Medios y metodos para evaluar el riesgo de intervenciones cardiacas basadas en el factor 15 de diferenciacion del crecimiento.
WO2008019375A3 (en) Proteomic patterns of cancer prognostic and predictive signatures
WO2007146385A3 (en) Albumin-bound protein/peptide complex as a biomarker for disease
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
WO2008012362A3 (en) New protein isoforms and uses thereof
WO2010061283A8 (en) Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
TW200801202A (en) Alpha-enolase specific antibody and method of use
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
WO2006113245A3 (en) Methods for measuring glycan levels of proteins
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
MX2009008525A (es) La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2006063133A3 (en) Biomarker for inflammatory bowel disease
WO2006124526A3 (en) Method for assessing the effectiveness of a treatment regimen by determining zonulin
WO2010035259A3 (en) Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll